vulnwire
8.8high

CVE-2007-6763

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources…

Published 7 y ago · modified 4 mo ago · JSON

CVSS
8.8
v3.0 · NVD
CISA KEV
No
not known exploited
EPSS
1.3%
percentile 71%
Public exploits
0
none known

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Exploit prediction (EPSS)

1.32% probability of exploitation in the next 30 days, higher than 71% of all scored CVEs.

CVSS scores

Assigned byVersionScoreVector
NVD3.08.8CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
NVD2.06.5AV:N/AC:L/Au:S/C:P/I:P/A:P

Classification

Weakness
  • CWE-20 Improper Input Validation

References

  • ftp.sas.com /techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf · x_refsource_MISC, x_transferred

Sources

vulnwire keeps one entry per vulnerability: the CVE id wins, then GHSA; records that alias each other are merged. Machine-readable: JSON.